Table 4.
Associations of SNPs with disease characteristics in the Dutch hospital-based ORIGO cohort of breast cancer patients
| Patient or disease characteristics | wt/wt | wt/mt | mt/mt | P value, three groupsa | P value, two groupsb |
| SNP rs2981582 (in FGFR2) | |||||
| Family history | |||||
| Positive for breast cancer (%) | 36 | 40 | 45 | 0.089 | 0.095 |
| Positive for breast cancer and/or ovarian cancer (%) | 38 | 42 | 48 | 0.065 | 0.089 |
| Average number of relatives with breast cancer or ovarian cancer divided by the total number of female relatives | 0.067 | 0.071 | 0.089 | 0.05 | 0.193 |
| Average duration of breastfeeding (months) | 4.5 | 5.5 | 5.8 | 0.224 | 0.062 |
| SNP rs3817198 (in LSP1) | |||||
| Positive lymph-node status (%) | 39 | 44 | 44 | 0.190 | 0.078 |
| SNP rs889312 (near MAP3K1) | |||||
| Positive lymph-node status (%) | 45 | 40 | 36 | 0.090 | 0.044 |
| SNP rs3803662 (near TNRC9) | |||||
| Age at diagnosis <60 years (%)c | 68 | 73 | 82 | 0.054 | 0.025 |
| Family history | |||||
| Average number of first-degree relatives with breast cancer | 0.23 | 0.28 | 0.31 | 0.156 | 0.072 |
| Average number of relatives with breast cancer divided by total number of female relatives | 0.063 | 0.070 | 0.082 | 0.166 | 0.118 |
| Average duration of breastfeeding (months) | 4.9 | 5.7 | 6.4 | 0.206 | 0.097 |
wt/wt, patients homozygous for the wildtype allele; wt/mt, patients heterozygous for the wildtype and mutated or minor allele; mt/mt, patients homozygous for the mutated or minor allele. aComparing the three genotype groups separately. bA codominant model, comparing the group of homozygous patients for the wildtype allele with the combined group of heterozygous patients and patients homozygous for the minor allele. cSee also Figure 1.